This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked COL15A1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-COL15A1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~141.7 kDa | |
| Gel | 8–10% (standard starting point) | |
| Positive control | Colon (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Cleaved | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A05581 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HEK293T (catalog A05581) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A05581; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
COL15A1 has a predicted 141.7 kDa precursor; cleavage, glycosylation and trimerization could affect migration, but no empirical band size is supplied.
| Band near 141.7 kDa | May represent the predicted precursor polypeptide; confirm identity with controls |
| Band above 141.7 kDa | May reflect the listed glycosylation sites; the size effect is unmeasured |
| Very high band under nonreducing conditions | May represent the disulfide-linked trimer |
| Band below the precursor position | May reflect removal of the signal peptide at residues 1–27 |
| Broad band or smear | May reflect variation in chondroitin sulfate modification at the listed serines |
| Little or no band in whole-cell lysate | Consistent with secretion into the extracellular matrix |
| Predicted precursor mass | 141.7 kDa is the sequence-based reference, not a measured band |
| Signal peptide at residues 1–27 | Cleavage may place the mature chain below the precursor |
| Chondroitin sulfate sites at Ser243, Ser247, Ser343 and Ser745 | Modification may raise and vary apparent size |
| O-linked site at Thr265 | Modification may alter apparent size; its effect is unmeasured |
| N-linked sites at Asn306, Asn324 and Asn687 | Modification may raise apparent size; the shift is unmeasured |
| Disulfide-linked trimer | May migrate much higher under nonreducing or incompletely reducing conditions |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | COL15A1 is secreted into the extracellular matrix | Check conditioned medium or extracellular matrix material |
| Band higher than expected | Glycosylation or a disulfide-linked trimer may affect migration | Compare reducing and nonreducing lanes and confirm identity with an independent antibody |
| Band lower than expected | Signal-peptide cleavage may remove residues 1–27 | Check whether the antibody recognizes the mature chain and confirm identity with a second epitope |
| Broad smear instead of sharp band | Chondroitin sulfate modification may vary | Compare appropriately treated and untreated samples with identity controls |
| Multiple bands | Monomer and disulfide-linked trimer may coexist after incomplete reduction | Compare fully reducing and nonreducing conditions |
| Weak or no signal | Secreted COL15A1 may be scarce in the sampled lysate | Enrich extracellular material and include a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Colon | endothelial cells | High | Protein (IHC) | HPA → |
| Skin | endothelial cells | High | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | Medium | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Medium | Protein (IHC) | HPA → |
| Kidney | cells in glomeruli | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for COL15A1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A05581 is a human-reactive anti-COL15A1 polyclonal antibody with a Western blot image using HEK293T whole cell lysate at 1:500 dilution. The supplied evidence covers this sample and condition only.
Which to pick: A05581 is the only listed option. Its Western blot image uses HEK293T whole cell lysate at 1:500; consider it for human samples while checking suitability for your own sample and protocol.